All posts tagged
Meet the Swedish Biotech that is Tackling NASH Through Mitochondria
French Biotech gets a Second Opportunity to Fight Liver Fibrosis
Genfit Delays Phase III Enrollment in the Race for the First NASH Therapy
Two Big Pharma Players Team up to Take Over the NASH Space
Why did Biotech Beat Pharma to Bring the First Gene Therapy to Market?
More News! Smart Lens looks More Distant & a Pollen Allergy Cure?
French Biotech gets a Boost in the NASH Race with a Successful IPO
Not to be Underestimated: What’s the Hype around NASH?
Top European VC and CRO fund Young Metabolic Disease Biotech
Shire sells its RNA platform to a US-based Biotech
This British Biotech is buying its way into the Crowded NASH Space
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
Labiotech UG, All Rights Reserved -
Send this to friend